As of 2012, 69% of countries holding membership in the WHO had recommended inclusion of a rubella-containing vaccine in the routine childhood vaccination schedule. One dose induces seroconversion in ≥95% of persons ≥1 year of age and provides long-term (potentially life-long) immunity.

• Pregnant women should not receive the vaccine, and pregnancy should be avoided for at least 28 days after vaccination.
• Immunoglobulin does not prevent rubella virus infection after exposure and therefore is not recommended as routine postexposure prophylaxis.